Skip to main content
. Author manuscript; available in PMC: 2018 Nov 8.
Published in final edited form as: J Clin Oncol Res. 2017 Aug 11;5(2):1058.

Figure 7.

Figure 7

TAM (F4/80+CD11b+) cells in the blood, tumors and lymph nodes (LN) sixteen (A–B) and twenty two (C–E) days post end of treatment. Group 1 no radiation, Group 2 radiation to the T1 tumor, Group 3 radiation to the T1 and T2 tumors. T1: right tumor T2: left tumor, T3: back tumor.